Matches in Wikidata for { <http://www.wikidata.org/entity/Q82674411> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- Q82674411 description "article scientifique publié en 2011" @default.
- Q82674411 description "artículu científicu espublizáu en payares de 2011" @default.
- Q82674411 description "im November 2011 veröffentlichter wissenschaftlicher Artikel" @default.
- Q82674411 description "scientific article published on 25 November 2011" @default.
- Q82674411 description "wetenschappelijk artikel" @default.
- Q82674411 description "наукова стаття, опублікована в листопаді 2011" @default.
- Q82674411 name "Second-line epidermal growth factor receptor inhibitors followed by third-line pemetrexed or the reverse sequence: a retrospective analysis of 83 Chinese patients with advanced lung adenocarcinoma" @default.
- Q82674411 name "Second-line epidermal growth factor receptor inhibitors followed by third-line pemetrexed or the reverse sequence: a retrospective analysis of 83 Chinese patients with advanced lung adenocarcinoma" @default.
- Q82674411 type Item @default.
- Q82674411 label "Second-line epidermal growth factor receptor inhibitors followed by third-line pemetrexed or the reverse sequence: a retrospective analysis of 83 Chinese patients with advanced lung adenocarcinoma" @default.
- Q82674411 label "Second-line epidermal growth factor receptor inhibitors followed by third-line pemetrexed or the reverse sequence: a retrospective analysis of 83 Chinese patients with advanced lung adenocarcinoma" @default.
- Q82674411 prefLabel "Second-line epidermal growth factor receptor inhibitors followed by third-line pemetrexed or the reverse sequence: a retrospective analysis of 83 Chinese patients with advanced lung adenocarcinoma" @default.
- Q82674411 prefLabel "Second-line epidermal growth factor receptor inhibitors followed by third-line pemetrexed or the reverse sequence: a retrospective analysis of 83 Chinese patients with advanced lung adenocarcinoma" @default.
- Q82674411 P1433 Q82674411-C1E62456-82FA-47F1-A9B8-116C7840E001 @default.
- Q82674411 P1476 Q82674411-D338078B-2B06-4375-9D70-9A5788E471FC @default.
- Q82674411 P2093 Q82674411-40E69A5B-12D3-4C60-AF18-01C97369C2EF @default.
- Q82674411 P2093 Q82674411-A7C8ECDF-2E5C-4D8B-82D0-9C2402EFBB81 @default.
- Q82674411 P2093 Q82674411-BBC012EF-642C-4FEC-82D1-35A7C0F1A8A1 @default.
- Q82674411 P2093 Q82674411-C43C568D-D44D-4A98-BF58-D5AAB560403A @default.
- Q82674411 P2093 Q82674411-E95E13BE-DEA8-4B3A-A7E9-DF812C212C94 @default.
- Q82674411 P2860 Q82674411-0A651B11-E88F-4E2C-BD06-C0C46DA52094 @default.
- Q82674411 P2860 Q82674411-0C45AB64-EAD5-4F6D-B13D-F5AE45BEBB11 @default.
- Q82674411 P2860 Q82674411-238BB1E4-E1AD-46F4-8048-2F7AEBFEAE5B @default.
- Q82674411 P2860 Q82674411-3D662952-3DF4-4DF3-8ADD-1857DC1885C2 @default.
- Q82674411 P2860 Q82674411-60DF4CFD-78D1-4DF8-A8BE-360EF90837F9 @default.
- Q82674411 P2860 Q82674411-6561C533-2FF3-4C19-ADBA-A987CC807655 @default.
- Q82674411 P2860 Q82674411-6958B999-8452-4C61-83CE-778229B75943 @default.
- Q82674411 P2860 Q82674411-6E9EF69A-0B30-4227-B596-991DA9BF89EE @default.
- Q82674411 P2860 Q82674411-83196E4C-EF96-4AD9-A241-2BB2F54EB204 @default.
- Q82674411 P2860 Q82674411-8C7F1760-03AA-44AD-93F1-421CA7F38867 @default.
- Q82674411 P2860 Q82674411-9747C5CB-907D-43A4-9620-A20D07B55059 @default.
- Q82674411 P2860 Q82674411-9F2ADB18-9FC7-4383-ABBE-4C1066DB0405 @default.
- Q82674411 P2860 Q82674411-C926B865-6282-496C-84CA-D6CA4186C8F3 @default.
- Q82674411 P2860 Q82674411-CBA5DEA6-B5F0-4C49-BA2C-FB40F1871AFA @default.
- Q82674411 P2860 Q82674411-D07460D8-04A7-4964-9866-E429235F44FF @default.
- Q82674411 P2860 Q82674411-DDE86DD8-2A15-43CB-90B4-3804927D7E16 @default.
- Q82674411 P2860 Q82674411-E71C8D4D-91E3-4855-A8FD-1D15A7E7817E @default.
- Q82674411 P2888 Q82674411-71AFB754-A4DB-4CC9-BABE-D05C219FF8F4 @default.
- Q82674411 P304 Q82674411-5E9BE884-0866-4108-A29D-77C78CF92B09 @default.
- Q82674411 P31 Q82674411-8EF02DF9-18AC-4D35-BDB1-BEEF293DE0F1 @default.
- Q82674411 P356 Q82674411-D5707C89-6471-4A90-BD3E-CFE0667EFF77 @default.
- Q82674411 P433 Q82674411-DEE2E81F-0034-4603-A0C1-E6EEE6500974 @default.
- Q82674411 P478 Q82674411-10F99C98-8276-4F9A-AEB8-B7D78B3F4543 @default.
- Q82674411 P577 Q82674411-8170C628-1BB7-46D8-82F4-C146C1912835 @default.
- Q82674411 P698 Q82674411-CC4EE504-E396-4413-8F22-AB359425F0E6 @default.
- Q82674411 P921 Q82674411-4C13D7B2-3B6F-4487-9D62-3C8CE4E67531 @default.
- Q82674411 P356 S00432-011-1084-Z @default.
- Q82674411 P698 22116317 @default.
- Q82674411 P1433 Q2081599 @default.
- Q82674411 P1476 "Second-line epidermal growth factor receptor inhibitors followed by third-line pemetrexed or the reverse sequence: a retrospective analysis of 83 Chinese patients with advanced lung adenocarcinoma" @default.
- Q82674411 P2093 "Dong Hua" @default.
- Q82674411 P2093 "Dongyan Cai" @default.
- Q82674411 P2093 "Ruxia Zhang" @default.
- Q82674411 P2093 "Tingting Hong" @default.
- Q82674411 P2093 "Xiaohong Wu" @default.
- Q82674411 P2860 Q24561953 @default.
- Q82674411 P2860 Q27860881 @default.
- Q82674411 P2860 Q29547545 @default.
- Q82674411 P2860 Q29547546 @default.
- Q82674411 P2860 Q29615475 @default.
- Q82674411 P2860 Q29620301 @default.
- Q82674411 P2860 Q29620605 @default.
- Q82674411 P2860 Q33379422 @default.
- Q82674411 P2860 Q34417512 @default.
- Q82674411 P2860 Q34546316 @default.
- Q82674411 P2860 Q34547495 @default.
- Q82674411 P2860 Q34559274 @default.
- Q82674411 P2860 Q36024588 @default.
- Q82674411 P2860 Q43274035 @default.
- Q82674411 P2860 Q45205054 @default.
- Q82674411 P2860 Q46232500 @default.
- Q82674411 P2860 Q46466769 @default.
- Q82674411 P2888 s00432-011-1084-z @default.
- Q82674411 P304 "285-291" @default.
- Q82674411 P31 Q13442814 @default.
- Q82674411 P356 "10.1007/S00432-011-1084-Z" @default.
- Q82674411 P433 "2" @default.
- Q82674411 P478 "138" @default.
- Q82674411 P577 "2011-11-25T00:00:00Z" @default.
- Q82674411 P698 "22116317" @default.
- Q82674411 P921 Q415220 @default.